How To Use CPT Code 90662

CPT 90662 refers to the administration of a preservative-free, split-virus influenza vaccine with enhanced immunogenicity via increased antigen content for intramuscular use. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes, and examples of CPT 90662.

1. What is CPT 90662?

CPT 90662 is a medical billing code used to describe the administration of a specific type of influenza vaccine. This vaccine is preservative-free, derived from a split virus, and contains increased antigen content to enhance the patient’s immune response. The vaccine is administered via intramuscular injection, typically in the upper arm.

2. 90662 CPT code description

The official description of CPT code 90662 is: “Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use.”

3. Procedure

1. The patient is appropriately prepped for the vaccine administration.
2. The provider counsels the patient on the vaccine, its benefits, and any potential side effects or precautions.
3. The provider selects the appropriate vaccine dosage based on the patient’s age and medical history.
4. The vaccine is drawn up into a sterile syringe.
5. The injection site on the patient’s upper arm is cleaned with an antiseptic solution.
6. The provider administers the vaccine via intramuscular injection, ensuring proper needle placement and technique.
7. After the injection, the provider applies a bandage to the injection site and provides the patient with any necessary aftercare instructions.

4. Qualifying circumstances

Patients eligible to receive CPT code 90662 services are those who require protection against the influenza virus and meet the following criteria:

• Individuals aged 6 months and older, as recommended by the Centers for Disease Control and Prevention (CDC).
• Patients with a history of severe allergic reactions to any component of the vaccine or a previous dose of any influenza vaccine.
• Individuals with a compromised immune system or certain chronic medical conditions, as determined by their healthcare provider.
• Pregnant women, as recommended by their healthcare provider.
• Healthcare workers and other individuals in close contact with high-risk populations.

5. When to use CPT code 90662

It is appropriate to bill the 90662 CPT code when a healthcare provider administers the preservative-free, split-virus influenza vaccine with enhanced immunogenicity to a patient who meets the qualifying circumstances outlined above. This code should be used for each administration of the vaccine, regardless of the number of doses required for full immunization.

6. Documentation requirements

To support a claim for CPT 90662, the following information must be documented in the patient’s medical record:

• Patient’s age, weight, and any relevant medical history.
• Indication for the vaccine, including any high-risk factors or medical conditions.
• Date of vaccine administration.
• Vaccine manufacturer, lot number, and expiration date.
• Specific vaccine product administered (i.e., CPT 90662).
• Route of administration (intramuscular).
• Injection site (e.g., left deltoid).
• Name, title, and signature of the healthcare provider administering the vaccine.

7. Billing guidelines

When billing for CPT code 90662, it is essential to follow the appropriate guidelines and rules to ensure accurate reimbursement. These include:

• Reporting separate codes for the vaccine administration, the actual vaccine product, and any associated office visit.
• Using the correct CPT code for the specific vaccine product administered (i.e., CPT 90662).
• Providing sufficient documentation to support the claim, as outlined in the documentation requirements section above.
• Adhering to any payer-specific guidelines or requirements for billing and reimbursement.

8. Historical information

CPT 90662 was added to the Current Procedural Terminology system on January 1, 2008. The code was updated on January 1, 2016, with a revised descriptor: “Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use.”

9. Similar codes to CPT 90662

There are several other CPT codes related to influenza vaccines that differ from CPT 90662 in various ways, such as the type of vaccine, antigen content, or administration method. These include:

• CPT 90653: A flu vaccine specifically designed for individuals aged 65 years and older, with an adjuvanted formulation to enhance the immune response.
• CPT 90656: A standard-dose, preservative-free, split-virus influenza vaccine for intramuscular use.
• CPT 90658: A standard-dose, split-virus influenza vaccine containing a preservative, for intramuscular use.
• CPT 90672: A live attenuated influenza vaccine (LAIV) administered via intranasal spray.
• CPT 90674: A cell culture-based, preservative-free, split-virus influenza vaccine for intramuscular use.

10. Examples

1. A 30-year-old patient with a history of asthma receives the CPT 90662 vaccine during their annual physical exam.
2. A 45-year-old healthcare worker receives the CPT 90662 vaccine to protect themselves and their patients during flu season.
3. A 60-year-old patient with diabetes receives the CPT 90662 vaccine as part of their routine preventive care.
4. A 25-year-old pregnant woman receives the CPT 90662 vaccine to protect herself and her unborn child from the flu.
5. A 50-year-old patient with a history of severe allergic reactions to preservatives in vaccines receives the CPT 90662 vaccine.
6. A 35-year-old patient with a compromised immune system due to HIV receives the CPT 90662 vaccine for added protection against the flu.
7. A 40-year-old patient with chronic obstructive pulmonary disease (COPD) receives the CPT 90662 vaccine to reduce their risk of flu-related complications.
8. A 55-year-old patient with a history of heart disease receives the CPT 90662 vaccine as part of their overall preventive care plan.
9. A 20-year-old college student living in a dormitory receives the CPT 90662 vaccine to protect themselves and their fellow students during flu season.
10. A 65-year-old patient with a history of cancer treatment receives the CPT 90662 vaccine to boost their immune response against the flu.